SCHEMBL21974355

SCHEMBL21974355

Cc1ccc(-c2ccc(-c3ccc(N(c4ccc(-c5ccc(-c6ccccc6)c6ccccc56)cc4)c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.45
KDM4E B2RXH2 2/20 0.45
ATM Q13315 1/20 0.45
AKR1C4 P17516 1/20 0.39
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
AKR1C1 Q04828 1/20 0.39
HDAC4 P56524 1/20 0.38
ALDH1A1 P00352 6/20 0.37
HTT P42858 2/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
HPGD P15428 1/20 0.36
PPARG P37231 1/20 0.36
NCOA2 Q15596 1/20 0.36
NCOA1 Q15788 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
COMT P21964 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21973717 1.00 L3MBTL1 (0.45) L3MBTL1KDM4EATMAKR1C4AKR1C3
SCHEMBL20009971 0.95 L3MBTL1 (0.45) L3MBTL1KDM4EATMAKR1C4AKR1C3
SCHEMBL15894182 0.94 KDM4E (0.50) L3MBTL1KDM4EATMAKR1C4AKR1C3
SCHEMBL10023642 0.94 KDM4E (0.50) L3MBTL1KDM4EATMAKR1C4AKR1C3
SCHEMBL20812723 0.94 KDM4E (0.50) L3MBTL1KDM4EATMAKR1C4AKR1C3
SCHEMBL20812985 0.94 KDM4E (0.50) L3MBTL1KDM4EATMAKR1C4AKR1C3
SCHEMBL24947183 0.93 L3MBTL1 (0.52) L3MBTL1KDM4EATMAKR1C4AKR1C3
SCHEMBL21973961 0.93 L3MBTL1 (0.52) L3MBTL1KDM4EATMAKR1C4AKR1C3
SCHEMBL13803712 0.93 TSPO (0.39) L3MBTL1KDM4EATMAKR1C4AKR1C3
SCHEMBL13803901 0.93 TSPO (0.39) L3MBTL1KDM4EATMAKR1C4AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11545630-B2 Compound and organic electroluminescent device comprising the same LG DISPLAY CO., LTD. (KR) 2023-01-03 US disclosed
US-20200144509-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME MATERIAL SCIENCE CO., LTD. (KR) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11545630-B2 Compound and organic electroluminescent device comprising the same PIEZO1, KCNN2, ORAI2 L3MBTL1 467/4885KDM4E 1244/4885ATM 3340/4885
US-20200144509-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME PIEZO1, KCNN2, HCN2 L3MBTL1 504/4885KDM4E 1210/4885ATM 3220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.